Summit Therapeutics Inc.

IPO

Summit Therapeutics Inc. is a biotech company in Miami, United States, founded in 2003. It has raised $500.0M across 3 rounds, most recently a Corporate Round in October 2025.

Committed to Optimizing Human Health

Headquarters
Miami, Florida
Employees
51–200
Founded
2003
Business Model
B2B
Website
smmttx.com
Total Funding
$500.0M
Last Round
Corporate RoundOct 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

Summit Therapeutics is a biopharmaceutical oncology company focused on discovering and commercializing patient-friendly cancer therapies. Its lead investigational therapy, ivonescimab, is a novel bispecific antibody combining PD-1 and VEGF blockade, currently in multiple Phase 3 clinical trials for non-small cell lung cancer and colorectal cancer. The company licensed ivonescimab from Akeso Inc. in 2023 for the US, Canada, Europe, Japan, and other territories.

Summary

It lists 51–200 employees. It has raised $500.0M in total across 3 rounds, most recently a Corporate Round in Oct 2025.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundOct 2025

Sign up to see all 4 events

Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Summit Therapeutics Inc. on Indexed.vc
<a href="https://indexed.vc/companies/summit-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/summit-therapeutics-inc" alt="Summit Therapeutics Inc. on Indexed.vc" width="260" height="76" /></a>